Literature DB >> 2530878

Amlodipine versus nadolol in patients with stable angina pectoris.

S Singh1, J Doherty, V Udhoji, K Smith, J Gorwit, S Bekheit, S Mather, W Stein, J San Fellippo, P Hearan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2530878     DOI： 10.1016/0002-8703(89)90848-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  4 in total

Review 1.  Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

Authors:  D Murdoch; R C Heel
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

2.  Amlodipine in patients with angina uncontrolled by atenolol. A double blind placebo controlled cross over trial.

Authors:  P A Woodmansey; A G Stewart; A H Morice; K S Channer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Antianginal effects of amlodipine at a single dose on exertional angina patients using treadmill exercise testing--a randomized crossover study in comparison with placebo.

Authors:  H Kishida; N Hata; T Kunimi; H Miyagawa; H Nishiyama; K Katoh
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

4.  Efficacy of amlodipine besilate therapy for variant angina: evaluation by 24-hour Holter monitoring.

Authors:  K Watanabe; T Izumi; Y Miyakita; S Koyama; M Ohshima; T Inomata; M Suzuki; M Takahashi; A Shibata
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.